Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.79
(
1.13%
)
Bitcoin
71,091.34
(
-0.21%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: corpstrat post# 74119

Monday, 03/09/2009 11:55:51 AM

Monday, March 09, 2009 11:55:51 AM

Post# of 257257

ZGEN – Is the albuferon news directionally bad for interferon lambda? Cos zgen is down even more than usual today.

Well, it clearly would’ve been better for ZGEN if the Albuferon trial had failed to meet the statistical threshold for non-inferiority; in that case, the drug would’ve been dead for all practical purposes. Nonetheless, the actual Albuferon outcome is certainly not a bad one for ZGEN, so I’m at a loss to explain the 5% drop today.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now